Literature DB >> 6604276

Changes in surface antigens of immature thymocytes under the influence of T-cell growth factor and thymic factors.

S S Chen, J S Tung, S Gillis, R A Good, J W Hadden.   

Abstract

Peanut agglutinin-positive thymocytes, peanut agglutinin-negative thymocytes, cortisone-resistant thymocytes, and unfractionated thymocytes were prepared from congeneic C57BL/6 Tla mice. By using surface iodination and immunoprecipitation of solubilized antigen with specific antisera (e.g., anti-H-2D, anti-TL, anti-Qa2/3, and anti-gp70), the released specific antigens were electrophoresed on polyacrylamide gels, and their radioactivity was measured. The relative percentages of surface antigens H-2D, TL, Qa2/3, and gp70 were 3.2%, 47.5%, 2.5%, and 46.8%, respectively, for peanut agglutinin-positive thymocytes; 31.8%, 4.4%, 32.7%, and 31.1%, respectively, for cortisone-resistant thymocytes; 13.2%, 28.7%, 12.3%, and 45.8%, respectively, for peanut agglutinin-negative thymocytes; and 7.7%, 27.1%, 4.3%, and 60.9%, respectively, for unfractionated thymocytes. After incubation with thymosin fraction V or T-cell growth factor (interleukin II) for 20 hr, the changes in surface antigens of peanut agglutinin-positive thymocytes closely correlated with their normal maturation (i.e., H-2D increases and TL decreases). Thymic factors (e.g., thymosin alpha 1, thymopoietin pentapeptide, facteur thymic serique) had only small or no effects on surface antigens of peanut agglutinin-positive thymocytes. The results suggest that peptides yet to be identified in thymosin fraction V may play an important role in intrathymic evolution and that T-cell growth factor is possibly a peripheral signal derived from activated T cells that modulates T-cell receptors and may be a critical regulator of intrathymic cellular development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604276      PMCID: PMC390201          DOI: 10.1073/pnas.80.19.5980

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  The generation and regulation of lymphocyte populations: evidence from differentiative induction systems in vitro.

Authors:  M P Scheid; G Goldstein; E A Boyse
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Sequential stages of human T lymphocyte differentiation.

Authors:  J L Touraine; J W Hadden; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

4.  The same genetic locus directs differentiation-linked expression of endogenous retrovirus gp70 on thymocytes and spleen cells in the mouse.

Authors:  J S Tung; F W Shen; G Viamontes; M Palladino; E Fleissner
Journal:  Immunogenetics       Date:  1982-01       Impact factor: 2.846

5.  Functional and molecular characteristics of T-cell growth factor.

Authors:  K A Smith; P E Baker; S Gillis; F W Ruscetti
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

6.  Ontogeny of murine T lymphocytes. I. Maturation of thymocytes induced in vitro by tumor necrosis factor-positive serum (TNF+)1,2.

Authors:  J Abbott; P J Doyle; K Ngiam; C L Olson
Journal:  Cell Immunol       Date:  1981-01-01       Impact factor: 4.868

7.  Expression of differentiation antigens in subpopulations of mouse thymocytes: regulation at the level of de novo synthesis.

Authors:  E Rothenberg
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

8.  A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.

Authors:  G Goldstein; M P Scheid; E A Boyse; D H Schlesinger; J Van Wauwe
Journal:  Science       Date:  1979-06-22       Impact factor: 47.728

9.  Thymus cell migration.

Authors:  I L Weissman
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

10.  Differentiation of T cells induced by preparations from thymus and by nonthymic agents.

Authors:  M P Scheid; M K Hoffmann; K Komuro; U Hämmerling; J Abbott; E A Boyse; G H Cohen; J A Hooper; R S Schulof; A L Goldstein
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Therapy of secondary T-cell immunodeficiencies with biological substances and drugs.

Authors:  J W Hadden; E M Hadden
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Analysis of thymic stromal cell subpopulations grown in vitro on extracellular matrix in defined medium. III. Growth conditions of human thymic epithelial cells and immunomodulatory activities in their culture supernatant.

Authors:  L Schreiber; I Eshel; A Meilin; Y Sharabi; J Shoham
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  New approaches to immunotherapy: thymomimetic drugs.

Authors:  S Specter; J W Hadden
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.

Authors:  M M Zatz; J Oliver; C Samuels; A B Skotnicki; M B Sztein; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine.

Authors:  A Hattori; H W Kunz; T J Gill; H Shinozuka
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.